Showing 4781-4790 of 5910 results for "".
- AstraZeneca’s COVID-19 Vaccine Shows 79% Efficacy in Pivotal US Studyhttps://modernod.com/news/astrazenecas-covid-19-vaccine-shows-79-efficacy-in-pivotal-us-study/2478995/AstraZeneca on Monday announced that its vaccine AZD1222 demonstrated efficacy of 79% at preventing symptomatic COVID-19 in a late-stage study conducted in the US. Results also showed that the vaccine had 100% efficacy at preventing severe disease and hospitalization, with comparable effectivenes
- SIFI Receives Marketing Authorization for Ophthalmic Products in in Turkeyhttps://modernod.com/news/sifi-recevies-marketing-authorizations-for-ophthalmic-products-in-in-turkey/2478996/SIFI, has announced that the Turkish Medicines and Medical Devices Agency (TMMDA) has approved the transfer of marketing authorizations from its former local distributor to its wholly owned subsidiary SIFI İlaç A.S. The approvals cover different formulations of ophthalmic drugs Netira, Netildex,
- Senate Narrowly Confirms Becerra as HHS Secretaryhttps://modernod.com/news/senate-narrowly-confirms-becerra-as-hhs-secretary/2478991/The Senate has narrowly confirmed California Attorney General Xavier Becerra as secretary of the Department of Health and Human Services, according to a FierceHealthcare
- EMA’s Blood Clot Review Exonerates AstraZeneca COVID-19 Vaccine, But Monitoring Continueshttps://modernod.com/news/emas-blood-clot-review-exonerates-astrazeneca-covid-19-vaccine-but-monitoring-continues/2478990/The European Medicines Agency (EMA) on Thursday said a review by its Pharmacovigilance Risk Assessment Committee (PRAC) has determined that AstraZeneca’s COVID-19 vaccine AZD1222 is safe and effective at preventing COVID-19, and that its benefits are “far greater” than any poten
- BJO Publishes New Data on Clearside Biomedical’s Investigational Treatment Xiperehttps://modernod.com/news/bjo-publishes-new-data-on-clearside-biomedicals-investigational-treatment-xipere/2478989/New data has been published in The British Journal of Ophthalmology related to the clinical development program of Clearside Biomedical’s Xipere, an investigational treatment with a proposed indication of macular edema associated with noninfectious uveitis.
- CorneaGen Names Bernie Iliakis Presidenthttps://modernod.com/news/corneagen-names-bernie-iliakis-president/2478979/CorneaGen announced that Bernardino “Bernie” Iliakis has been promoted from chief operating officer to president of the company. Mr. Iliakis will assume leadership of the company as part of Monty Montoya’s transition from CEO to strategic advisor to CorneaGen.
- Moderna Gives First Vaccine Shots To Young Kids As Part Of COVID-19 Studyhttps://modernod.com/news/moderna-gives-first-vaccine-shots-to-young-kids-as-part-of-covid-19-study/2478978/Children have now received their first doses of Moderna’s COVID-19 vaccine, as the company studies the safety and effectiveness of the vaccine for kids ages 6 months to less than 12 years old, according to an NPR
- Newly Formed Ophthalmology Foundation Will Improve Global Eye Care Through Educationhttps://modernod.com/news/newly-formed-ophthalmology-foundation-will-improve-global-eye-care-through-education/2478972/The newly incorporated nonprofit Ophthalmology Foundation is laying the groundwork to improve global eye care and ophthalmic practice, particularly in low-resource and underserved countries, according to a company news release. Led by a global board of ophthalmologists, ophthalmology professors,
- EU Greenlights J&J’s Coronavirus Vaccinehttps://modernod.com/news/eu-greenlights-jjs-coronavirus-vaccine/2478966/The European Commission granted a conditional marketing authorization for Johnson & Johnson’s single-dose COVID-19 vaccine Ad26.COV2.S in people 18 years of age and over. The decision comes just hours after the European Medicines Agency (EMA) gave its backing following a review of ̶
- CORE Offers Tips on Seeking Eye Care During the Pandemic, Provides Free Infographics for ECPs to Use with Patientshttps://modernod.com/news/core-offers-tips-on-seeking-eye-care-during-the-pandemic-provides-free-infographics-for-ecps-to-use-with-patients/2478959/As the global COVID-19 pandemic enters its second year, a new initiative from the Centre for Ocular Research & Education (CORE) is addresses questions that may keep people from seeking proper eye care. CORE has designed